Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Renal Denervation in Hypertensive Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05460169 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.

NCT NCT05460169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05460169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Renal Denervation in Hypertensive Patients With Autosomal Dominant Polycystic Kidney Disease
Lead sponsor
University of Erlangen-Nürnberg Medical School
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 14, 2022
Completion date
March 31, 2028
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney disease, renal denervation, uncontrolled hypertension